Bone and Soft Tissue Oncology
A section of Current Oncology (ISSN 1718-7729).
Section Information
Soft tissue and bone sarcomas are rare and aggressive tumors that suffer from limited evidence supporting therapeutic decision making in many clinical situations and for different subsets of patients.
This section aims to encourage the publication of preclinical and clinical data for evidence-based therapeutic algorithms.
Topics of interest for this section include, but are not limited to:
- Preclinical background supporting the design of innovative clinical trials;
- Retrospective and prospective case series reporting the natural history of very rare sarcomas;
- Retrospective and prospective case series reporting the activity and the efficacy of anticancer drugs in specific sarcoma histotypes, provided there is a huge effort in assessing histological diagnosis and treatment outcomes;
- Prospective clinical trials;
- Perspectives on debated topics of major clinical relevance, supported by in-depth analysis of the literature.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- An In-Depth Review of Desmoid Tumours (Deadline: 31 December 2024)
- The Evolving Role of Surgery in Multidisciplinary Care for Sarcoma Patients (Deadline: 30 April 2025)
- 2nd Edition: Treatment of Bone Metastasis (Deadline: 15 July 2025)
